We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VBS market cap is 3.99M. The company's latest EPS is AUD -0.0439 and P/E is -1.59.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 50k | 1.02M | 1.3M | 1.3M | 1.06M |
| Operating Income | -2.67M | -2.79M | -3.3M | -3.29M | -2.41M |
| Net Income | -3M | -3.86M | -3.99M | -3.44M | -2.34M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3M | 6.98M | 3.94M | 4.63M | 2.03M |
| Total Liabilities | 8.64M | 8.87M | 7.47M | 863k | 540k |
| Total Equity | -5.65M | -1.89M | -3.53M | 3.77M | 1.49M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3M | -3.26M | -4.44M | -2.35M | -2.03M |
| Investing | N/A | N/A | -21k | -17k | -68k |
| Financing | 5.64M | 6.35M | -35k | 4.04M | -41k |
| Market Cap | 3.99M |
| Price to Earnings Ratio | -1.59 |
| Price to Sales Ratio | 3.5 |
| Price to Cash Ratio | 4.61 |
| Price to Book Ratio | 2.51 |
| Dividend Yield | - |
| Shares Outstanding | 53.21M |
| Average Volume (1 week) | 75.3k |
| Average Volume (1 Month) | 31.13k |
| 52 Week Change | -70.00% |
| 52 Week High | 0.295 |
| 52 Week Low | 0.075 |
| Spread (Intraday) | -0.01 (-7.04%) |
| Company Name | Vectus Biosystems Limited |
| Address |
unit 5 sydney, new south wales 2018 |
| Website | https://www.vectusbiosystems.com.au |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
